Use of direct-probe mass spectrometry as a toxicology confirmation method for demoxepam in urine following high-performance liquid chromatography

MLA

Steven R. Binder, et al. “Use of Direct-Probe Mass Spectrometry as a Toxicology Confirmation Method for Demoxepam in Urine Following High-Performance Liquid Chromatography.” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 683, Aug. 1996, pp. 199–208. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a5c66cd0f4e7a84e205ddf6cea9ea4a4&authtype=sso&custid=ns315887.

APA

Steven R. Binder, David L. King, Herbert Essien, & Shih-Tse Jason Lai. (1996). Use of direct-probe mass spectrometry as a toxicology confirmation method for demoxepam in urine following high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, 683, 199–208.

Chicago

Steven R. Binder, David L. King, Herbert Essien, and Shih-Tse Jason Lai. 1996. “Use of Direct-Probe Mass Spectrometry as a Toxicology Confirmation Method for Demoxepam in Urine Following High-Performance Liquid Chromatography.” Journal of Chromatography B: Biomedical Sciences and Applications 683 (August): 199–208. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a5c66cd0f4e7a84e205ddf6cea9ea4a4&authtype=sso&custid=ns315887.